These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38629365)

  • 41. RNF144B-mediated p21 degradation regulated by HDAC3 contribute to enhancing ovarian cancer growth and metastasis.
    Zhuang H; Zhang Z; Wang W; Qu H
    Tissue Cell; 2024 Feb; 86():102277. PubMed ID: 37992458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Galectin-1 induces metastasis and epithelial-mesenchymal transition (EMT) in human ovarian cancer cells via activation of the MAPK JNK/p38 signalling pathway.
    Zhu J; Zheng Y; Zhang H; Liu Y; Sun H; Zhang P
    Am J Transl Res; 2019; 11(6):3862-3878. PubMed ID: 31312395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor RUNX1T1.
    Sun T; Yang P; Gao Y
    Exp Physiol; 2020 Jan; 105(1):75-87. PubMed ID: 31645082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway.
    Zhao N; Wang C; Guo P; Hou J; Yang H; Lan T; Zhou Y; Li J; Bhawal UK; Liu Y
    Bioengineered; 2022 Apr; 13(4):10956-10972. PubMed ID: 35484984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction between human initiation factor eIF3 subunit c and heat-shock protein 90: a necessary factor for translation mediated by the hepatitis C virus internal ribosome entry site.
    Ujino S; Nishitsuji H; Sugiyama R; Suzuki H; Hishiki T; Sugiyama K; Shimotohno K; Takaku H
    Virus Res; 2012 Jan; 163(1):390-5. PubMed ID: 22016036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-27a regulates the proliferation, chemosensitivity and invasion of human ovarian cancer cell lines by targeting Cullin 5.
    Si L; Jia Y; Lin R; Jian W; Yu Q; Yang S
    Arch Biochem Biophys; 2019 Jun; 668():9-15. PubMed ID: 31047870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. E2F8 Induces Cell Proliferation and Invasion through the Epithelial-Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer.
    Eoh KJ; Kim HJ; Lee JW; Kim LK; Park SA; Kim HS; Kim YT; Koo PJ
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.
    Huang L; Zhong L; Cheng R; Chang L; Qin M; Liang H; Liao Z
    Aging (Albany NY); 2023 Sep; 15(18):9676-9694. PubMed ID: 37728413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a/b.
    Zhang F; Luo BH; Wu QH; Li QL; Yang KD
    Mol Med; 2022 Jan; 28(1):2. PubMed ID: 34983361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
    Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
    Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
    Liu T; Qin W; Hou L; Huang Y
    Tumour Biol; 2015 Mar; 36(3):1881-93. PubMed ID: 25510663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
    Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
    J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway.
    Yan L; He Z; Li W; Liu N; Gao S
    Cell Cycle; 2021 Sep; 20(18):1875-1889. PubMed ID: 34382920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
    Li J; Huang H; Li Y; Li L; Hou W; You Z
    Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SPTBN2 regulates endometroid ovarian cancer cell proliferation, invasion and migration via ITGB4‑mediated focal adhesion and ECM receptor signalling pathway.
    Yang L; Gu Y
    Exp Ther Med; 2023 Jun; 25(6):277. PubMed ID: 37206547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer.
    Tian Y; Liu LL; Guo DM; Wang Y; Zha WH; Li Y; Wu FJ
    J Cell Biochem; 2018 Sep; 119(9):7540-7555. PubMed ID: 29904936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer.
    Singh MS; Ramishetti S; Landesman-Milo D; Goldsmith M; Chatterjee S; Palakuri R; Peer D
    Small; 2021 May; 17(19):e2100287. PubMed ID: 33825318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
    Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
    J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells.
    Shen X; Jin X; Fang S; Chen J
    Cell Mol Biol Lett; 2023 Jul; 28(1):53. PubMed ID: 37420173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression.
    Li M; Deng Y; Zhuo M; Zhou H; Kong X; Xia X; Su Z; Chen Q; Guo P; Mo P; Yu C; Li W
    Theranostics; 2020; 10(19):8863-8879. PubMed ID: 32754284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.